Groowe Groowe / Newsroom / ALGS
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ALGS News

Aligos Therapeutics, Inc. Common Stock

Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates

globenewswire.com
ALGS

7MM Chronic Hepatitis B Therapeutics Market Drug Forecast and Market Analysis Report 2024-2034: Addressing Unmet Needs, Late-Stage Pipelines and Functional Cure Therapies Drive Growth

globenewswire.com
GSK GILD ALGS

Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of James Hassard as Executive Vice President, Chief Commercial Officer

globenewswire.com
ALGS

Onco3R Therapeutics Appoints Lawrence Blatt as Chair of the Board for Onco3R Therapeutics

globenewswire.com
ALGS JNJ

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

globenewswire.com
ALGS

Aligos Therapeutics Presents Positive Data at HEP-DART 2025

globenewswire.com
ALGS

NAMU Introduces Recovery Slide Featuring SoleicĀ® -- High-Performance and Microplastics-Free Polyurethane

prnewswire.com
ALGS

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

globenewswire.com
ALGS

Aligos Therapeutics Presents Positive Data at The Liver MeetingĀ® 2025

globenewswire.com
ALGS

Aligos Therapeutics to Present at Upcoming Investor Conferences

globenewswire.com
ALGS